nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ABCB1—peripheral nervous system neoplasm	0.196	1	CbGaD
Caffeine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0407	0.0831	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.035	0.0714	CbGbCtD
Caffeine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0326	0.0665	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0326	0.0665	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.027	0.0552	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0266	0.0543	CbGbCtD
Caffeine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0244	0.0499	CbGbCtD
Caffeine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0235	0.0479	CbGbCtD
Caffeine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0195	0.0399	CbGbCtD
Caffeine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0171	0.0349	CbGbCtD
Caffeine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0171	0.0349	CbGbCtD
Caffeine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0164	0.0334	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0156	0.0319	CbGbCtD
Caffeine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0149	0.0305	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0149	0.0305	CbGbCtD
Caffeine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0132	0.027	CbGbCtD
Caffeine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0118	0.0242	CbGbCtD
Caffeine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0112	0.0229	CbGbCtD
Caffeine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0103	0.021	CbGbCtD
Caffeine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0102	0.0209	CbGbCtD
Caffeine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00988	0.0202	CbGbCtD
Caffeine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00952	0.0194	CbGbCtD
Caffeine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00765	0.0156	CbGbCtD
Caffeine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0073	0.0149	CbGbCtD
Caffeine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00701	0.0143	CbGbCtD
Caffeine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00681	0.0139	CbGbCtD
Caffeine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00669	0.0137	CbGbCtD
Caffeine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00456	0.00931	CbGbCtD
Caffeine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00437	0.00893	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0043	0.00878	CbGbCtD
Caffeine—PIK3CB—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00417	0.865	CbGdCrCtD
Caffeine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00401	0.00818	CbGbCtD
Caffeine—PIK3CD—nerve—peripheral nervous system neoplasm	0.00372	0.0952	CbGeAlD
Caffeine—PIK3CB—nerve—peripheral nervous system neoplasm	0.00324	0.083	CbGeAlD
Caffeine—PIK3CA—nerve—peripheral nervous system neoplasm	0.00321	0.0822	CbGeAlD
Caffeine—Necrotising colitis—Epirubicin—peripheral nervous system neoplasm	0.00282	0.0263	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.0256	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Tretinoin—peripheral nervous system neoplasm	0.00274	0.0256	CcSEcCtD
Caffeine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.00558	CbGbCtD
Caffeine—Necrotising colitis—Doxorubicin—peripheral nervous system neoplasm	0.00261	0.0243	CcSEcCtD
Caffeine—Impaired healing—Isotretinoin—peripheral nervous system neoplasm	0.00226	0.0211	CcSEcCtD
Caffeine—Impaired healing—Tretinoin—peripheral nervous system neoplasm	0.00226	0.0211	CcSEcCtD
Caffeine—Impaired healing—Melphalan—peripheral nervous system neoplasm	0.00223	0.0209	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.0194	CcSEcCtD
Caffeine—ADORA2A—ganglion—peripheral nervous system neoplasm	0.00194	0.0497	CbGeAlD
Caffeine—PRKDC—trigeminal ganglion—peripheral nervous system neoplasm	0.00192	0.0492	CbGeAlD
Caffeine—PIK3CD—trigeminal ganglion—peripheral nervous system neoplasm	0.0018	0.0462	CbGeAlD
Caffeine—ATM—brainstem—peripheral nervous system neoplasm	0.0018	0.0461	CbGeAlD
Caffeine—Cerebral haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00177	0.0165	CcSEcCtD
Caffeine—Acidosis—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.0165	CcSEcCtD
Caffeine—Acidosis—Tretinoin—peripheral nervous system neoplasm	0.00177	0.0165	CcSEcCtD
Caffeine—Cerebral haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.0165	CcSEcCtD
Caffeine—Impaired healing—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.016	CcSEcCtD
Caffeine—ADORA1—nerve—peripheral nervous system neoplasm	0.0017	0.0434	CbGeAlD
Caffeine—ADORA1—ganglion—peripheral nervous system neoplasm	0.00168	0.0429	CbGeAlD
Caffeine—PIK3CB—trigeminal ganglion—peripheral nervous system neoplasm	0.00157	0.0403	CbGeAlD
Caffeine—RYR1—trigeminal ganglion—peripheral nervous system neoplasm	0.00156	0.0399	CbGeAlD
Caffeine—PIK3CA—trigeminal ganglion—peripheral nervous system neoplasm	0.00156	0.0399	CbGeAlD
Caffeine—Hypercalcaemia—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.0132	CcSEcCtD
Caffeine—Hypercalcaemia—Tretinoin—peripheral nervous system neoplasm	0.00141	0.0132	CcSEcCtD
Caffeine—PIK3CB—brainstem—peripheral nervous system neoplasm	0.00139	0.0356	CbGeAlD
Caffeine—PIK3CA—brainstem—peripheral nervous system neoplasm	0.00138	0.0353	CbGeAlD
Caffeine—Cerebral haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.0125	CcSEcCtD
Caffeine—Acidosis—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.0125	CcSEcCtD
Caffeine—Cerebral haemorrhage—Vincristine—peripheral nervous system neoplasm	0.00129	0.0121	CcSEcCtD
Caffeine—ADORA2B—trigeminal ganglion—peripheral nervous system neoplasm	0.00115	0.0293	CbGeAlD
Caffeine—Hypercalcaemia—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00997	CcSEcCtD
Caffeine—ATM—cerebellum—peripheral nervous system neoplasm	0.000888	0.0227	CbGeAlD
Caffeine—Pulmonary oedema—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00814	CcSEcCtD
Caffeine—Pulmonary oedema—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00814	CcSEcCtD
Caffeine—Sepsis—Topotecan—peripheral nervous system neoplasm	0.000856	0.008	CcSEcCtD
Caffeine—Sepsis—Tretinoin—peripheral nervous system neoplasm	0.00085	0.00794	CcSEcCtD
Caffeine—Sepsis—Isotretinoin—peripheral nervous system neoplasm	0.00085	0.00794	CcSEcCtD
Caffeine—PRKDC—cerebellum—peripheral nervous system neoplasm	0.00084	0.0215	CbGeAlD
Caffeine—ADORA1—trigeminal ganglion—peripheral nervous system neoplasm	0.000823	0.0211	CbGeAlD
Caffeine—Deafness—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00742	CcSEcCtD
Caffeine—Deafness—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00742	CcSEcCtD
Caffeine—PIK3CD—cerebellum—peripheral nervous system neoplasm	0.000787	0.0201	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000711	0.00664	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000711	0.00664	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—peripheral nervous system neoplasm	0.000694	0.00649	CcSEcCtD
Caffeine—PIK3CB—cerebellum—peripheral nervous system neoplasm	0.000687	0.0176	CbGeAlD
Caffeine—RYR1—cerebellum—peripheral nervous system neoplasm	0.00068	0.0174	CbGeAlD
Caffeine—PIK3CA—cerebellum—peripheral nervous system neoplasm	0.00068	0.0174	CbGeAlD
Caffeine—Irritability—Tretinoin—peripheral nervous system neoplasm	0.000678	0.00634	CcSEcCtD
Caffeine—Irritability—Isotretinoin—peripheral nervous system neoplasm	0.000678	0.00634	CcSEcCtD
Caffeine—Blood creatinine increased—Tretinoin—peripheral nervous system neoplasm	0.000666	0.00622	CcSEcCtD
Caffeine—Blood creatinine increased—Isotretinoin—peripheral nervous system neoplasm	0.000666	0.00622	CcSEcCtD
Caffeine—Pulmonary oedema—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00617	CcSEcCtD
Caffeine—PRKDC—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000652	0.135	CbGdCrCtD
Caffeine—Dry skin—Tretinoin—peripheral nervous system neoplasm	0.000651	0.00608	CcSEcCtD
Caffeine—Dry skin—Isotretinoin—peripheral nervous system neoplasm	0.000651	0.00608	CcSEcCtD
Caffeine—Urine output increased—Vincristine—peripheral nervous system neoplasm	0.000646	0.00604	CcSEcCtD
Caffeine—Sepsis—Alitretinoin—peripheral nervous system neoplasm	0.000644	0.00601	CcSEcCtD
Caffeine—Gastritis—Tretinoin—peripheral nervous system neoplasm	0.000629	0.00587	CcSEcCtD
Caffeine—Gastritis—Isotretinoin—peripheral nervous system neoplasm	0.000629	0.00587	CcSEcCtD
Caffeine—PDE4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000609	0.0156	CbGeAlD
Caffeine—Deafness—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00562	CcSEcCtD
Caffeine—Deafness—Vincristine—peripheral nervous system neoplasm	0.00058	0.00542	CcSEcCtD
Caffeine—PDE4B—parotid gland—peripheral nervous system neoplasm	0.000574	0.0147	CbGeAlD
Caffeine—Infestation NOS—Topotecan—peripheral nervous system neoplasm	0.000552	0.00516	CcSEcCtD
Caffeine—Infestation—Topotecan—peripheral nervous system neoplasm	0.000552	0.00516	CcSEcCtD
Caffeine—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.000548	0.00512	CcSEcCtD
Caffeine—Infestation—Tretinoin—peripheral nervous system neoplasm	0.000548	0.00512	CcSEcCtD
Caffeine—Infestation NOS—Isotretinoin—peripheral nervous system neoplasm	0.000548	0.00512	CcSEcCtD
Caffeine—Infestation NOS—Tretinoin—peripheral nervous system neoplasm	0.000548	0.00512	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000539	0.00503	CcSEcCtD
Caffeine—Renal failure—Isotretinoin—peripheral nervous system neoplasm	0.000538	0.00503	CcSEcCtD
Caffeine—Renal failure—Tretinoin—peripheral nervous system neoplasm	0.000538	0.00503	CcSEcCtD
Caffeine—Irritability—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.0048	CcSEcCtD
Caffeine—Deafness—Cisplatin—peripheral nervous system neoplasm	0.000513	0.00479	CcSEcCtD
Caffeine—Blood creatinine increased—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.00471	CcSEcCtD
Caffeine—Sepsis—Etoposide—peripheral nervous system neoplasm	0.000503	0.00469	CcSEcCtD
Caffeine—ADORA2B—cerebellum—peripheral nervous system neoplasm	0.0005	0.0128	CbGeAlD
Caffeine—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.000498	0.00465	CcSEcCtD
Caffeine—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.000496	0.00463	CcSEcCtD
Caffeine—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.000494	0.00462	CcSEcCtD
Caffeine—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.000494	0.00462	CcSEcCtD
Caffeine—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.000494	0.00461	CcSEcCtD
Caffeine—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000492	0.00459	CcSEcCtD
Caffeine—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000492	0.00459	CcSEcCtD
Caffeine—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.000488	0.00456	CcSEcCtD
Caffeine—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.000485	0.00453	CcSEcCtD
Caffeine—Gastritis—Alitretinoin—peripheral nervous system neoplasm	0.000477	0.00445	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—peripheral nervous system neoplasm	0.000467	0.00436	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.000459	0.00429	CcSEcCtD
Caffeine—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000448	0.00418	CcSEcCtD
Caffeine—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000438	0.00409	CcSEcCtD
Caffeine—Irritability—Cisplatin—peripheral nervous system neoplasm	0.000438	0.00409	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.00404	CcSEcCtD
Caffeine—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.000431	0.00403	CcSEcCtD
Caffeine—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.00043	0.00402	CcSEcCtD
Caffeine—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.000428	0.004	CcSEcCtD
Caffeine—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.000428	0.004	CcSEcCtD
Caffeine—ADORA2A—cerebellum—peripheral nervous system neoplasm	0.000416	0.0106	CbGeAlD
Caffeine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00388	CcSEcCtD
Caffeine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00388	CcSEcCtD
Caffeine—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00388	CcSEcCtD
Caffeine—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00388	CcSEcCtD
Caffeine—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.00381	CcSEcCtD
Caffeine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.000393	0.00367	CcSEcCtD
Caffeine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.000393	0.00367	CcSEcCtD
Caffeine—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.000374	0.0035	CcSEcCtD
Caffeine—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.00348	CcSEcCtD
Caffeine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000371	0.00346	CcSEcCtD
Caffeine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000371	0.00346	CcSEcCtD
Caffeine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000369	0.00345	CcSEcCtD
Caffeine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000369	0.00345	CcSEcCtD
Caffeine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000366	0.00342	CcSEcCtD
Caffeine—ADORA1—cerebellum—peripheral nervous system neoplasm	0.000359	0.00919	CbGeAlD
Caffeine—Infection—Topotecan—peripheral nervous system neoplasm	0.00035	0.00327	CcSEcCtD
Caffeine—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000348	0.0089	CbGeAlD
Caffeine—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.000348	0.00325	CcSEcCtD
Caffeine—Infection—Tretinoin—peripheral nervous system neoplasm	0.000347	0.00324	CcSEcCtD
Caffeine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000347	0.00324	CcSEcCtD
Caffeine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000345	0.00323	CcSEcCtD
Caffeine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000343	0.0032	CcSEcCtD
Caffeine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000343	0.0032	CcSEcCtD
Caffeine—Infection—Melphalan—peripheral nervous system neoplasm	0.000342	0.0032	CcSEcCtD
Caffeine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000342	0.00319	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00319	CcSEcCtD
Caffeine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00318	CcSEcCtD
Caffeine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00318	CcSEcCtD
Caffeine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00317	CcSEcCtD
Caffeine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00317	CcSEcCtD
Caffeine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000336	0.00314	CcSEcCtD
Caffeine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000335	0.00313	CcSEcCtD
Caffeine—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000333	0.00311	CcSEcCtD
Caffeine—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00303	CcSEcCtD
Caffeine—Infestation—Etoposide—peripheral nervous system neoplasm	0.000324	0.00303	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000324	0.00303	CcSEcCtD
Caffeine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.000318	0.00297	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.00295	CcSEcCtD
Caffeine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00294	CcSEcCtD
Caffeine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000314	0.00293	CcSEcCtD
Caffeine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00291	CcSEcCtD
Caffeine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00291	CcSEcCtD
Caffeine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000307	0.00287	CcSEcCtD
Caffeine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000304	0.00284	CcSEcCtD
Caffeine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000302	0.00282	CcSEcCtD
Caffeine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.00282	CcSEcCtD
Caffeine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00278	CcSEcCtD
Caffeine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000298	0.00278	CcSEcCtD
Caffeine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000295	0.00275	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000289	0.0027	CcSEcCtD
Caffeine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000287	0.00268	CcSEcCtD
Caffeine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00268	CcSEcCtD
Caffeine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000284	0.00265	CcSEcCtD
Caffeine—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00263	CcSEcCtD
Caffeine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00262	CcSEcCtD
Caffeine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00262	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000276	0.00258	CcSEcCtD
Caffeine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000271	0.00253	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00027	0.00252	CcSEcCtD
Caffeine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00027	0.00252	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.0025	CcSEcCtD
Caffeine—PDE4B—cerebellum—peripheral nervous system neoplasm	0.000266	0.0068	CbGeAlD
Caffeine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00246	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000263	0.00245	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00243	CcSEcCtD
Caffeine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00026	0.00242	CcSEcCtD
Caffeine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000259	0.00242	CcSEcCtD
Caffeine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00241	CcSEcCtD
Caffeine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000257	0.0024	CcSEcCtD
Caffeine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.0024	CcSEcCtD
Caffeine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.0024	CcSEcCtD
Caffeine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000254	0.00237	CcSEcCtD
Caffeine—Infection—Vincristine—peripheral nervous system neoplasm	0.000253	0.00237	CcSEcCtD
Caffeine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00025	0.00234	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00226	CcSEcCtD
Caffeine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00224	CcSEcCtD
Caffeine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.0022	CcSEcCtD
Caffeine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000236	0.00603	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000236	0.0022	CcSEcCtD
Caffeine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00213	CcSEcCtD
Caffeine—CYP1B1—cerebellum—peripheral nervous system neoplasm	0.000228	0.00583	CbGeAlD
Caffeine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00209	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00209	CcSEcCtD
Caffeine—Rash—Topotecan—peripheral nervous system neoplasm	0.000222	0.00207	CcSEcCtD
Caffeine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000222	0.00207	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000221	0.00207	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00206	CcSEcCtD
Caffeine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.00206	CcSEcCtD
Caffeine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000219	0.00205	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00205	CcSEcCtD
Caffeine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000219	0.00204	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00204	CcSEcCtD
Caffeine—Rash—Melphalan—peripheral nervous system neoplasm	0.000217	0.00203	CcSEcCtD
Caffeine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000217	0.00203	CcSEcCtD
Caffeine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00202	CcSEcCtD
Caffeine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00196	CcSEcCtD
Caffeine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00195	CcSEcCtD
Caffeine—Infection—Etoposide—peripheral nervous system neoplasm	0.000205	0.00192	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00191	CcSEcCtD
Caffeine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000202	0.00188	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00188	CcSEcCtD
Caffeine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000201	0.00187	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00187	CcSEcCtD
Caffeine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00182	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000195	0.00182	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.0018	CcSEcCtD
Caffeine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000192	0.0049	CbGeAlD
Caffeine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000188	0.00176	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000184	0.00172	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00172	CcSEcCtD
Caffeine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000182	0.0017	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000182	0.0017	CcSEcCtD
Caffeine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.00168	CcSEcCtD
Caffeine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00167	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000178	0.00167	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00159	CcSEcCtD
Caffeine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00157	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00157	CcSEcCtD
Caffeine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00156	CcSEcCtD
Caffeine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00156	CcSEcCtD
Caffeine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00155	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00154	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00153	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00152	CcSEcCtD
Caffeine—Rash—Vincristine—peripheral nervous system neoplasm	0.000161	0.0015	CcSEcCtD
Caffeine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000161	0.0015	CcSEcCtD
Caffeine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000152	0.00142	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00142	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00141	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00141	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00138	CcSEcCtD
Caffeine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000147	0.00376	CbGeAlD
Caffeine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000142	0.00133	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000142	0.00133	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00133	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00131	CcSEcCtD
Caffeine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00129	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00127	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00123	CcSEcCtD
Caffeine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00122	CcSEcCtD
Caffeine—Rash—Etoposide—peripheral nervous system neoplasm	0.00013	0.00122	CcSEcCtD
Caffeine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00013	0.00122	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00119	CcSEcCtD
Caffeine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00115	CcSEcCtD
Caffeine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00114	CcSEcCtD
Caffeine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00113	CcSEcCtD
Caffeine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000116	0.00297	CbGeAlD
Caffeine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00107	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00106	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00106	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00106	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00106	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00105	CcSEcCtD
Caffeine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000994	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000982	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000977	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000972	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000964	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000934	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000892	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000864	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000797	CcSEcCtD
Caffeine—ABCB1—cerebellum—peripheral nervous system neoplasm	8.36e-05	0.00214	CbGeAlD
Caffeine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000737	CcSEcCtD
Caffeine—Rash—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000682	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000681	CcSEcCtD
Caffeine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000631	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000631	CcSEcCtD
Caffeine—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.56e-05	9.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.55e-05	9.47e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—ERBB2—peripheral nervous system neoplasm	1.53e-05	9.37e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.53e-05	9.35e-05	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HRAS—peripheral nervous system neoplasm	1.53e-05	9.34e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—PTPN11—peripheral nervous system neoplasm	1.53e-05	9.34e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	9.3e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.52e-05	9.29e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	9.28e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.52e-05	9.26e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.5e-05	9.18e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.49e-05	9.11e-05	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.49e-05	9.07e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.48e-05	9.01e-05	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.47e-05	8.95e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.47e-05	8.95e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.44e-05	8.81e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.44e-05	8.79e-05	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.44e-05	8.78e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	8.77e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.43e-05	8.71e-05	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.43e-05	8.71e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.42e-05	8.69e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—ERBB2—peripheral nervous system neoplasm	1.42e-05	8.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTPN11—peripheral nervous system neoplasm	1.41e-05	8.62e-05	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.41e-05	8.59e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.38e-05	8.44e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.38e-05	8.43e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.37e-05	8.38e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.37e-05	8.35e-05	CbGpPWpGaD
Caffeine—PRKDC—Immune System—AKT1—peripheral nervous system neoplasm	1.35e-05	8.25e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.34e-05	8.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—peripheral nervous system neoplasm	1.34e-05	8.19e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—NRAS—peripheral nervous system neoplasm	1.34e-05	8.17e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.33e-05	8.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.32e-05	8.04e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.31e-05	7.99e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.3e-05	7.91e-05	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.29e-05	7.9e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.29e-05	7.9e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—HRAS—peripheral nervous system neoplasm	1.28e-05	7.83e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.28e-05	7.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.28e-05	7.8e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.27e-05	7.73e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.26e-05	7.66e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.24e-05	7.59e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.24e-05	7.59e-05	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.24e-05	7.59e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NRAS—peripheral nervous system neoplasm	1.24e-05	7.55e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.23e-05	7.53e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.22e-05	7.43e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—ERBB2—peripheral nervous system neoplasm	1.21e-05	7.38e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.19e-05	7.28e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.17e-05	7.17e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.17e-05	7.15e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NRAS—peripheral nervous system neoplasm	1.17e-05	7.13e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.17e-05	7.12e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.16e-05	7.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.16e-05	7.05e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—MYC—peripheral nervous system neoplasm	1.15e-05	7.03e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.15e-05	7e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.14e-05	6.96e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.14e-05	6.95e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—AKT1—peripheral nervous system neoplasm	1.13e-05	6.92e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-05	6.86e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—ERBB2—peripheral nervous system neoplasm	1.12e-05	6.81e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.11e-05	6.8e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.11e-05	6.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.11e-05	6.77e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.1e-05	6.7e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.08e-05	6.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NRAS—peripheral nervous system neoplasm	1.08e-05	6.58e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.08e-05	6.57e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.07e-05	6.55e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.07e-05	6.54e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.06e-05	6.49e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.06e-05	6.47e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.06e-05	6.45e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.04e-05	6.38e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.04e-05	6.37e-05	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.04e-05	6.36e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.03e-05	6.31e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.02e-05	6.24e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.02e-05	6.23e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	6.15e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—MYC—peripheral nervous system neoplasm	1e-05	6.13e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	1e-05	6.11e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.98e-06	6.09e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	9.93e-06	6.06e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	9.92e-06	6.06e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.92e-06	6.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.89e-06	6.04e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.83e-06	6e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HRAS—peripheral nervous system neoplasm	9.8e-06	5.98e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9.8e-06	5.98e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.74e-06	5.95e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	9.51e-06	5.81e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.47e-06	5.78e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	9.43e-06	5.76e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.35e-06	5.71e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.26e-06	5.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NRAS—peripheral nervous system neoplasm	9.2e-06	5.62e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	9.16e-06	5.59e-05	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.09e-06	5.55e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HRAS—peripheral nervous system neoplasm	9.04e-06	5.52e-05	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9e-06	5.5e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9e-06	5.5e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	8.95e-06	5.47e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.92e-06	5.45e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.79e-06	5.36e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.66e-06	5.29e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—AKT1—peripheral nervous system neoplasm	8.65e-06	5.28e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.64e-06	5.28e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HRAS—peripheral nervous system neoplasm	8.54e-06	5.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NRAS—peripheral nervous system neoplasm	8.49e-06	5.18e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	8.45e-06	5.16e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	8.43e-06	5.15e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.4e-06	5.13e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.36e-06	5.1e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.31e-06	5.07e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.26e-06	5.04e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.25e-06	5.04e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.18e-06	4.99e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.16e-06	4.98e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.06e-06	4.92e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.06e-06	4.92e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.04e-06	4.91e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—AKT1—peripheral nervous system neoplasm	7.99e-06	4.88e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	7.97e-06	4.86e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	7.95e-06	4.85e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.93e-06	4.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MYC—peripheral nervous system neoplasm	7.91e-06	4.83e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—peripheral nervous system neoplasm	7.88e-06	4.81e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.87e-06	4.81e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.82e-06	4.77e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.78e-06	4.75e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.66e-06	4.68e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.66e-06	4.67e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.6e-06	4.64e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.58e-06	4.63e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.56e-06	4.62e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.55e-06	4.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—AKT1—peripheral nervous system neoplasm	7.54e-06	4.6e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.53e-06	4.6e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.49e-06	4.58e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	7.49e-06	4.57e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.48e-06	4.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.36e-06	4.5e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.34e-06	4.48e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.3e-06	4.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.16e-06	4.37e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	7.1e-06	4.33e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.09e-06	4.33e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.09e-06	4.33e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.07e-06	4.31e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.04e-06	4.3e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.03e-06	4.29e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.97e-06	4.25e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.96e-06	4.25e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—peripheral nervous system neoplasm	6.96e-06	4.25e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.95e-06	4.24e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.87e-06	4.19e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.87e-06	4.19e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—peripheral nervous system neoplasm	6.73e-06	4.11e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—peripheral nervous system neoplasm	6.69e-06	4.08e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.62e-06	4.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.5e-06	3.97e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	6.49e-06	3.96e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	6.47e-06	3.95e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.45e-06	3.94e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.36e-06	3.89e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.36e-06	3.88e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.36e-06	3.88e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.35e-06	3.88e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.33e-06	3.87e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.28e-06	3.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—peripheral nervous system neoplasm	6.21e-06	3.79e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.12e-06	3.73e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.08e-06	3.71e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.07e-06	3.71e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.01e-06	3.67e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6e-06	3.66e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6e-06	3.66e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.98e-06	3.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.95e-06	3.63e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.94e-06	3.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—peripheral nervous system neoplasm	5.94e-06	3.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.92e-06	3.62e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.91e-06	3.61e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.86e-06	3.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.85e-06	3.57e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—peripheral nervous system neoplasm	5.83e-06	3.56e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.77e-06	3.52e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.72e-06	3.49e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.72e-06	3.49e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.67e-06	3.46e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.64e-06	3.44e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.61e-06	3.42e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.59e-06	3.41e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.59e-06	3.41e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.54e-06	3.38e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.52e-06	3.37e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.5e-06	3.36e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—peripheral nervous system neoplasm	5.49e-06	3.35e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.47e-06	3.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.37e-06	3.28e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.08e-06	3.1e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.91e-06	3e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.88e-06	2.98e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.87e-06	2.98e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.86e-06	2.97e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.85e-06	2.96e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.83e-06	2.95e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.81e-06	2.93e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.78e-06	2.92e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.65e-06	2.84e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.64e-06	2.83e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.6e-06	2.81e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.6e-06	2.81e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—peripheral nervous system neoplasm	4.59e-06	2.8e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.57e-06	2.79e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.56e-06	2.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.55e-06	2.78e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.52e-06	2.76e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.48e-06	2.73e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.35e-06	2.66e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.11e-06	2.51e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.06e-06	2.48e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.92e-06	2.39e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.9e-06	2.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.84e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.83e-06	2.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.75e-06	2.29e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.74e-06	2.28e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.69e-06	2.25e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.59e-06	2.19e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.17e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.01e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.95e-06	1.8e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.68e-06	1.64e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.42e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.51e-06	9.24e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	8.05e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.24e-06	7.58e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	7.52e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.05e-06	6.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.12e-07	4.96e-06	CbGpPWpGaD
